ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

    G. Sapisochin, N. Goldaracena, J. Laurence, A. Barbas, M. Dib, A. Ghanekar, M. Selzner, L. Lilly, I. McGilvray, M. Cattral, E. Renner, P. Greig, D. Grant.

    Multi-Organ Transplant, Toronto General Hospital. University of Toronto, Toronto, ON, Canada.

    The role of liver transplantation for patients whose HCC exceeds Milan criteria remains controversial. At the University of Toronto, we have reported survivals of a…
  • 2015 American Transplant Congress

    An Analysis of Health-Related Quality of Life in Liver Transplantion for Hepatocellular Carcinoma

    C. Kensinger, H. O'Dell, D. LaNeve, L. Simmons, I. Feurer, D. Moore.

    Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN.

    Background:There is a disproportionate waiting time and an unclear survival benefit between hepatocellular carcinoma (HCC) versus non-HCC liver transplant recipients. However, there is paucity of…
  • 2015 American Transplant Congress

    Pediatric Liver Transplantation: An Outcome Analysis of a 30-Year Single Center Experience

    A. Weissenbacher,1 C. Margreiter,1 R. Oberhuber,1 M. Maglione,1 B. Cardini,1 J. Grahammer,1 T. Müller,2 R. Margreiter,1 S. Schneeberger.1

    1Department for Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria; 2Department of Paediatrics I, Innsbruck Medical University, Innsbruck, Austria.

    Introduction: In this study we aim to assess factors influencing long-term patient and graft survival as well as surgical parameters and risk factors influencing organ…
  • 2015 American Transplant Congress

    Preemptive Rituximab Therapy of Epstein-Barr Virus (EBV) Infection to Prevent Post-Transplant Lymphoproliferative Disease (PTLD) After Pediatric Solid Organ Transplantation (SOT)

    Y. Ahn,1 N.-J. Yi,2 S. Min,2 I.-S. Ha,1 H. Cheong,1 H. Kang.1

    1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea; 2Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

    Purpose: More than 90% of pediatric PTLD after solid organ transplantation is associated with EBV infection. Reduction in immunosuppression is the first step to prevent…
  • 2015 American Transplant Congress

    IL-2-Dependent Natural Killer Cell Responses to Epstein-Barr Virus B Cell Lymphomas Involve the NKG2A/NKG2C Axis

    O. Hatton, D. Strauss-Albee, C. Blish, C. Esquivel, S. Krams, O. Martines.

    Stanford University School of Medicine, Stanford, CA.

    Epstein Barr virus (EBV) infection elicits a strong host immune response that is considered to be essential for control of the virus and for preventing…
  • 2015 American Transplant Congress

    T-Cell Immune Function Vs. Gene Expression Profiling for Heart Transplant Rejection

    M. Luu, M. Kittleson, J. Patel, F. Liou, S. Siddiqui, L. Piponniau, A. Hage, D. Chang, L. Czer, A. Trento, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Purpose: Non-invasive immune monitoring of heart transplant (HTx) patients (pts) is increasing in use. The AlloMap® blood test has proven helpful in surveillance of cardiac…
  • 2015 American Transplant Congress

    Incidence and Characteristics of CMV Infection in High Risk (D+R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis

    M. Bhattarai, C. Puttarajappa, G. Mour, C. Wu, P. Sood, N. Shah, R. Mehta, A. Tevar, S. Hariharan.

    Internal Medicine, University of Pittsburgh, Pittsburgh, PA.

    Cytomegalovirus (CMV) infection is the most common opportunistic viral infection after renal transplantation. Optimal duration of antiviral prophylaxis and the role of post prophylaxis surveillance…
  • 2015 American Transplant Congress

    A Novel Humanized Mouse Model for the Study of Induced Pluripotent Stem Cell-Derived Tissue Transplantation Tolerance and Function

    M. Brown, I. Norman, Y. Zhou, J. Sullivan, W. Burlingham.

    Surgery/Transplant Division, University of Wisconsin-Madison, Madison, WI.

    Patient-specific induced pluripotent stem cells (iPSCs) hold great promise for regenerative medicine therapies, theoretically allowing for the creation of autologous replacement tissues devoid of many…
  • 2015 American Transplant Congress

    Invasive CMV-Infection of the Duodenal Cuff – An Underestimated Entity of CMV Infection and Its Potential Impact On Outcome After Pancreas Transplantation

    A. Biglarnia,1 B. von Zur-Mühlen,1 S. Yamamoto,1 D. Berglund,1 M. Wagner,2 A. Sedigh,1 G. Tufveson,1 E. Larsson,3 F. Sund.2

    1Transplantation, Surgical Sciences, Uppsala, Sweden; 2Medical Scinces, Upsala, Sweden; 3Genetics and Pathology, Uppsala, Sweden.

    IntroductionWe present data on the incidence of focal invasive CMV-infection of the duodenal cuff and its potential impact on clinical outcome after pancreas transplantation (PT).Material…
  • 2015 American Transplant Congress

    Furthering the Link Between Ischemia and Immunity: Development of New Antibody Following Prolonged Delayed Graft Function

    A. Gilbert,1 E. Hall,1 O. Timofeeva,2 M. Awwad,2 M. Grafals,1 P. Weems,1 D. Li,2 S. Rosen-Bronson,2 J. Moore,1 B. Javaid,1 M. Cooper.1

    1Department of Surgery, MedStar Georgetown Transplant Institute, Washington, DC; 2Department of Pathology, MedStar Georgetown Transplant Institute, Washington, DC.

    Introduction The purpose of this study is to examine the relationship between prolonged ischemia (delayed graft function - DGF) and the development of de novo…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences